Literature DB >> 1730354

Ciclosporin (Sandimmun) therapy: experience in the treatment of pars planitis and present therapeutic guidelines.

R B Nussenblatt1, A G Palestine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1730354     DOI： 10.1159/000429649

Source DB:  PubMed          Journal:  Dev Ophthalmol        ISSN： 0250-3751


× No keyword cloud information.
  5 in total

1.  Clinical characteristics of intermediate uveitis in Tunisian patients.

Authors:  Moncef Khairallah; Kamel Hmidi; Sonia Attia; Bechir Jelliti; Wafa Hasnaoui; Sonia Zaouali; Salah Jenzeri; Salim Ben Yahia; Riadh Messaoud
Journal:  Int Ophthalmol       Date:  2010-03-05       Impact factor: 2.031

2.  Analysis of clinical features and visual outcomes of pars planitis.

Authors:  Nilufer Berker; Emine Sen; Ufuk Elgin; Cemile Ucgul Atilgan; Erdem Dursun; Pelin Yilmazbas
Journal:  Int Ophthalmol       Date:  2017-04-07       Impact factor: 2.031

Review 3.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

4.  Pars planitis: epidemiology and clinical outcome in a large community hospital in Mexico City.

Authors:  G Ortega-Larrocea; L Arellanes-Garcia
Journal:  Int Ophthalmol       Date:  1995       Impact factor: 2.031

Review 5.  Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis.

Authors:  Pinar Cakar Ozdal; Nilufer Berker; Ilknur Tugal-Tutkun
Journal:  J Ophthalmic Vis Res       Date:  2015 Oct-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.